KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Shares Outstanding (Diluted Average) (2020 - 2025)

GoodRx Holdings (GDRX) has disclosed Shares Outstanding (Diluted Average) for 6 consecutive years, with $357.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) fell 8.98% to $357.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $357.0 million through Dec 2025, down 8.98% year-over-year, with the annual reading at $357.0 million for FY2025, 8.98% down from the prior year.
  • Shares Outstanding (Diluted Average) hit $357.0 million in Q4 2025 for GoodRx Holdings, up from $347.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $416.4 million in Q3 2023 to a low of $347.8 million in Q3 2025.
  • Historically, Shares Outstanding (Diluted Average) has averaged $393.7 million across 5 years, with a median of $401.1 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 49.25% in 2021 and later fell 10.47% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $410.0 million in 2021, then rose by 0.7% to $412.9 million in 2022, then dropped by 0.62% to $410.3 million in 2023, then decreased by 4.42% to $392.2 million in 2024, then decreased by 8.98% to $357.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for GDRX at $357.0 million in Q4 2025, $347.8 million in Q3 2025, and $357.2 million in Q2 2025.